https://www.camurus.com/sv/media/pressmeddelanden/2020/forandring-av-antalet-aktier-och-roster-i-camurus-2020-07-31/
Förändring av antalet aktier och röster i Camurus - Camurus
antaletaktierochcamurus
https://medicalhub.camurus.com/posteraccess/enea2025/
ENEA 2025 - Camurus Medical Hub
eneacamurusmedicalhub
https://www.camurus.com/sv/media/pressmeddelanden/2025/buvidal-vecko-och-manadsdepa-nu-tillganglig-for-patienter-i-schweiz/
Buvidal® vecko- och månadsdepå – nu tillgänglig för patienter i Schweiz - Camurus
veckoochpatienterschweizcamurus
https://medicalhub.camurus.com/disease-areas/
Disease areas - Camurus Medical Hub
disease areascamurusmedicalhub
https://www.drugdeliverybusiness.com/camurus-touts-study-of-depot-injection-for-opioid-dependence/
Camurus touts study of depot injection for opioid dependence - Drug Delivery Business
May 11, 2021 - Camurus announced positive study results for its monthly buprenorphine depot injections (Buvidal) for treating opioid dependence.
depot injectionopioid dependencedrug deliverycamurustouts